STOP T1D

03/06/2026

New in out of the Netherlands: "'Over 6 months, the urinary albumin-to-creatinine ratio (UACR) decreased by 34% in participants on finerenone compared with 12% in those on placebo (geometric mean ratio 0.75, 95% CI 0.65-0.87, P

First new drug in 30 years to slow kidney disease in type 1 diabetes

03/05/2026

The development of the drug Teplizumab (Tzield) has been a turning point for delaying Stage 3 onset.

Read more about what we've learned since it's emergence in 2022 as a treatment: "Changing the Course of Type 1 Diabetes - Breakthrough T1D " > https://www.breakthrought1d.org/news-and-updates/changing-type-1-diabetes/

Tzield is the first approved disease-modifying therapy for type 1 diabetes. Breakthrough T1D is working to make sure it’s not the last.

03/05/2026

Happening tomorrow, March 5 at noon ET online! > Saliva-based At-home GRS Testing for Scalable and Accessible T1D Screening https://thesugarscience.substack.com/p/saliva-based-at-home-grs-testing

Ahead of tomorrow's talk by Yuta Matsuda PhD

03/03/2026

Fasting for Ramadan? Here are recent findings out of Saudi Arabia that indicate managing using an automated insulin delivery system ( ) while fasting results in better glycemic control, thereby reducing the risk of hypoglycemia.

"Use of AID during Ramadan fasting was associated with fasting the most days of Ramadan, best glycemic control, and the least frequent hypoglycemia avoidance behaviors. The International Diabetes Federation/Diabetes and Ramadan International Alliance risk calculator should consider a lower risk score for AID technology when used by PWT1D."

Insulin delivery modality and fasting interruption, glycemic control, and fear of hypoglycemia in type 1 diabetes: a prospective, multicenter study from Saudi Arabia https://www.diabetesresearchclinicalpractice.com/article/S0168-8227(26)00115-4/abstract

Most people with type 1 diabetes (PWT1D) typically avoid fasting during Ramadan because of dysglycemia risks. We compared efficacy, safety profiles, and fear of hypoglycemia (FOH) during Ramadan fasting in users of four insulin delivery modalities.

03/02/2026

✅ Ask the Experts Office Hours Resumes March 18, 2026. Hosted by the Ask the Experts Team from the Barbara Davis Center for Diabetes and STOP T1D

This 1-Hour Zoom-session will be held on:
Wednesday March 18, 2026
NOON (MST) / 2 PM (EST)

Please come prepared to discuss early cases you may have questions about. Attendees will also have the opportunity to ask general questions related to early screening and follow-up monitoring.

We look forward to your attendance and participation!

REGISTER to Join: https://www.asktheexperts.org/office-hours-mar18

The University of Colorado School of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The University of Colorado School of Medicine designates this live activity for a maximum of 1 AMA PRA Category 1 Credits.™ Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Ask the Experts and this Office Hours program is supported by The Leona M. and Harry B. Helmsley Charitable Trust.

Registration Form for our monthly "Office Hours" Zoom call for HCPs — to discuss early T1D questions and cases.

02/27/2026

Understand the signs, symptoms, and treatments for .

What is Type 1 Diabetes? - Getting Ahead of Type 1 Diabetes https://www.gettingaheadoftype1.org/what-is-type-1-diabetes -is-type-1-diabetes

Unlike other types of diabetes, type 1 diabetes (T1D) is a lifelong autoimmune disease that is currently not preventable or curable.

02/26/2026

New in : "Orbital Apex Syndrome (OAS) is a disease of multiple brain nerves at the orbital apex leading to vision loss and neurological impairments. Diabetes Mellitus (DM), a metabolic disorder with cardiovascular, immunological and neurological effects, is involved in OAS pathogenesis. However, the association between DM and OAS is not well studied. DM and OAS are poorly understood and may not be diagnosed correctly, especially when outbreaks such as COVID-19 are being investigated."

"The overview summarizes what clinicians need to do: Screen all OAS patients for DM, conduct stepwise diagnostic evaluations (including history taking and imaging tests), and MDT [multidisciplinary team] care to balance glycemic control with OAS treatment. Future work should focus on mechanistic biomarkers, diagnostic innovations, and personalized care for OAS patients."

Frontiers | Unveiling the hidden link: diabetes mellitus as a catalyst for orbital apex syndrome https://www.frontiersin.org/journals/endocrinology/articles/10.3389/fendo.2026.1770045/full

BackgroundOrbital Apex Syndrome (OAS) is a disease of multiple brain nerves at the orbital apex leading to vision loss and neurological impairments. Diabetes...

02/25/2026

Now we need to address affordability and access to get AIDs into use for more people managing their using CGMs.

"Results from this trial show the clinical efficacy of direct transition from multiple daily injections to tubeless AID in adults and children with type 1 diabetes, with no safety concerns, supporting AID as a therapeutic option within standard of care for people with type 1 diabetes."

"Tubeless automated insulin delivery versus multiple daily injections in children and adults with type 1 diabetes with elevated HbA1c (RADIANT): a multicentre, international, parallel-group, open-label, randomised, controlled trial" https://www.thelancet.com/journals/landia/article/PIIS2213-8587(25)00364-X/abstract

Results from this trial show the clinical efficacy of direct transition from multiple daily injections to tubeless AID in adults and children with type 1 diabetes, with no safety concerns, supporting AID as a therapeutic option within standard of care for people with type 1 diabetes.

02/23/2026

Here's is the second live panel expert discussion hosted by The Sugar Science, made available for your viewing on YouTube: https://youtu.be/4rW_f6O8FL4?si=RBegxmb895czY9Cb

Enjoy the videos and music you love, upload original content, and share it all with friends, family, and the world on YouTube.

02/20/2026

In case you weren't able to attend this live panel discussion on screenings put on by The Sugar Science, it's now available to view on YouTube: https://youtu.be/jZIFm9YoxWU?si=wsbm49mtLSZC3E_i

Enjoy the videos and music you love, upload original content, and share it all with friends, family, and the world on YouTube.

02/20/2026

Health Care Providers: Why screen for pre-symptomatic type 1 diabetes? We have 5 good reasons to share with you from the Barbara Davis Center for Diabetes' Ask the Experts and STOP T1D programs.

Learn more:
AskTheExperts.org/for-providers
STOPT1Dprogram.org/for-HCP
BarbaraDavisCenter.org

02/18/2026

Know the signs and symptoms of type 1 diabetes!

See the accompanying graphic for the most common T1D symptoms.

To learn more, visit BarbaraDavisCenter.org and STOPT1Dprogram.org.

For no cost and disease screening information, visit ASKhealth.org